View All Bridgewest Group Investment Portfolio Assets

Drug CRDMO

Third largest global contract research, development and manufacturing organization (CRDMO) that provides biopharmaceutical partners with fully integrated services to support drug discovery, development and manufacturing for both drug substance and drug product.

2005 year invested
Dr. Armin Spura, CEO ›

Biologics CDMO

Global, multi-product biologics contract development and manufacturing organization (CDMO), with end-to-end drug substance and sterile fill-finish manufacturing services, spanning both large and small molecules, with expertise in microbial, pDNA, and RNA.

2020 year invested
Mark W. Womack, CEO ›

Sterile Injectable Drug Products

Global supplier of sterile injectable pharmaceutical drugs spanning high potency, blow fill seal and multi format vials.

2023 year invested
Mark Crotty, Interim CEO ›

Conditionally Active Biologics

Global clinical-stage biotechnology company utilizing proprietary Conditionally Active Biologics (CAB) technology to develop novel monoclonal antibody and other protein therapeutic product candidates with more selective targeting, greater efficacy, and more cost-efficient and predictable manufacturing than traditional antibodies.

2010 year invested
Dr. Jay Short, CEO ›

Smart Document Management

SuiteFiles is a cloud based document management system for small and medium businesses.

2019 year invested
Andrew Sims, CEO ›

Intelligent Business Management

An intelligent business management platform, built by professional services, for professional services.

2019 year invested
Mark Orttung, CEO ›

Enterprise Software Solution

An award-winning global technology services firm and a proud Microsoft Partner with Gold Status across numerous competencies. Provoke helps its clients flourish by delivering well-engineered, impactful software on time, on budget, and always hitting the mark.

2017 year invested
Andy Lin, CEO ›

Biopharmaceutical Company

Preclinical biopharmaceutical company developing single-target and combo-therapeutic CAR-T therapies that are fine-tuned to comprehensively target a patient's solid tumors and their microenvironments.

2019 year invested
Dr. Laurence Cooper,
Executive Chairman ›

IP Services

An R&D service company providing development services for state of the art IP, product design, and technology platforms.

2014 year invested
Massih Tayebi, CEO ›

Smart Audio & Power Management

A fabless semiconductor company providing state of the art, disruptive chipset solutions in Power Management and Smart Audio across a wide spectrum of applications from Mobile devices, IoT, Personal Computers, and Cloud Servers.

2019 year invested

Intelligence Location Services

The power of location intelligence is at work, enabling businesses to create frictionless experiences. Macro- and micro-location solutions turn physical-world data into action for operators, marketers, and analysts looking to improve their omnichannel strategies.

2014 year invested

Preclinical Biopharmaceutical

Preclinical biopharmaceutical development company focusing on best-in-class small and large molecule therapeutics, and cell-therapy, to address the unmet medical needs of patients.

2015 year invested

Automated Manufacturing of CAR-T cell

BioOra Limited is a partnership between Bridgewest Ventures and the Malaghan Institute of Medical Research. Through automated manufacturing of CAR-T cell immunotherapy, BioOra can deliver life-saving immunotherapies at substantially less cost.

2021 year invested
John Robson,
Managing Director ›

Software Test Automation

A Bridgewest Ventures New Zealand Incubator company that delivers a test automation platform, SaaS, and ERP automated testing and release management, leveraging AI to lower costs and de-risk software upgrade acceptance.

2021 year invested
Dan Diefendorf,
Chair and CEO ›

AI Solutions & Services

Pioneering advancements in Artificial Intelligence leverage expert data science for AI algorithms and IOT smart devices from edge to cloud, that garner meaningful sensory data insights and establish critical building blocks for ethical AI.

2021 year invested
Saba Samiei,
Founder and President ›

Enterprise Software Development

A software development company that develops, maintains, and enhances software solutions to help companies build digital products and scale teams. Modernization and optimization of business software solutions through dedicated teams enable companies to focus on the core aspects of running their business.

2022 year invested
Nataša Zec, CEO ›

Bionanorod-based Immunodiagnostics

Pioneers of the biological scalable nanorod technology platform with applications in immunodiagnostics.

2022 year invested
Paul Smith, CEO ›

Biotechnology Company

A biotechnology company leveraging patented 3D printed chromatography columns for separating and purifying biological molecules from a fluid mixture. Serving the medicinal therapeutics industry, enabling purification of DNA, RNA, viruses, and antibodies used in vaccines and cell and gene therapies.

2022 year invested
Dr. Sean Feast, CEO ›

Surgical Tools

A medical technology company with a novel revascularization device to help plastic surgeons restore form and function for patients who are left disfigured from disease and deformity.

2022 year invested
Dr. Nandoun Abeysekera, CEO ›

Ophthalmic Therapeutics

TheiaNova is developing transformative, new, non-invasive therapies for patients with vision impairment due to ectatic vision disorders.

2022 year invested
Dr. Carissa Fonseca, CEO ›

Sustainable Bio-Performance

A future-driven bio-based foamed material platform that addresses the global plastics crisis by enabling current polystyrene factory equipment to mold a sustainably sourced, functional replacement for Styrofoam with potential for multiple end of life options.

2023 year invested
Sarah Heine, CEO ›

Commercial Lighting and Controls

Highly engineered, specification grade commercial lighting solutions designed with application centric approach and compatibility for a broad range of controls.

2017 year invested

Real Estate

Real estate company with a broad global portfolio spanning speciality commerical sites, business centers, residential and mixed-used buildings.

2009 year invested
Evan Wilson,
Global Head of Real Estate ›

Skin Cancer Screening Tool

Luminoma is pioneering a non-invasive skin cancer screening tool. By detecting molecular changes in cells, Luminoma delivers rapid and accurate diagnosis, reducing patient stress and healthcare system burden.

2023 year invested
Maher Khaled, CEO, Founder ›

Sustainable Plastics Manufacturing

Compostify creates certified, home-compostable bioplastics that decompose within a year, restoring soil nutrients without leaving microplastics. Backed by Scion, their solutions set a global standard for sustainable plastics.

2024 year invested
Steve Wilson, CEO, Founder ›

Battery Materials

High-performance materials that provide significant improvements in energy density, capacity retention and scalability for next-generation batteries.

2025 year invested
Will Haringa,
Commercial Lead ›

Our Investment Portfolio